Selected research
Market Structure
Global Atracurium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Atracurium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Atracurium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Atracurium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Atracurium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Atracurium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Atracurium include HOSPIRA, Joshi & Company, ZHEJIANG HAISEN PHARMACEUICAL, GSK, Jiangsu Hengrui Medicine, Dongying (Jiangsu) Pharmaceutical and Zhejiang Xianju Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Atracurium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Atracurium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Atracurium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atracurium market size, projected growth trends, production technologies, key applications, and end-use industries.
Atracurium Segment by Company
HOSPIRA
Joshi & Company
ZHEJIANG HAISEN PHARMACEUICAL
GSK
Jiangsu Hengrui Medicine
Dongying (Jiangsu) Pharmaceutical
Zhejiang Xianju Pharmaceutical
Atracurium Segment by Type
25mg
50mg
Atracurium Segment by Application
Clinic
Hospital
ASCs
Others
Atracurium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atracurium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atracurium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atracurium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Atracurium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Atracurium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atracurium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Atracurium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 25mg
- 50mg
Applications
- Clinic
- Hospital
- ASCs
- Others
Companies covered
- HOSPIRA
- Joshi & Company
- ZHEJIANG HAISEN PHARMACEUICAL
- GSK
- Jiangsu Hengrui Medicine
- Dongying (Jiangsu) Pharmaceutical
- Zhejiang Xianju Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Atracurium Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Atracurium Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Atracurium Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Atracurium Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Atracurium Market Dynamics
- 2.1 Atracurium Industry Trends
- 2.2 Atracurium Industry Drivers
- 2.3 Atracurium Industry Opportunities and Challenges
- 2.4 Atracurium Industry Restraints
3 Atracurium Market by Manufacturers
- 3.1 Global Atracurium Revenue by Manufacturers (2021-2026)
- 3.2 Global Atracurium Sales by Manufacturers (2021-2026)
- 3.3 Global Atracurium Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Atracurium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Atracurium Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Atracurium Manufacturers, Product Type & Application
- 3.7 Global Atracurium Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Atracurium Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Atracurium Players Market Share by Revenue in 2025
- 3.8.3 2025 Atracurium Tier 1, Tier 2, and Tier 3
4 Atracurium Market by Type
- 4.1 Atracurium Type Introduction
- 4.1.1 25mg
- 4.1.2 50mg
- 4.2 Global Atracurium Sales by Type
- 4.2.1 Global Atracurium Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Atracurium Sales by Type (2021-2032)
- 4.2.3 Global Atracurium Sales Market Share by Type (2021-2032)
- 4.3 Global Atracurium Revenue by Type
- 4.3.1 Global Atracurium Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Atracurium Revenue by Type (2021-2032)
- 4.3.3 Global Atracurium Revenue Market Share by Type (2021-2032)
5 Atracurium Market by Application
- 5.1 Atracurium Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 ASCs
- 5.1.4 Others
- 5.2 Global Atracurium Sales by Application
- 5.2.1 Global Atracurium Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Atracurium Sales by Application (2021-2032)
- 5.2.3 Global Atracurium Sales Market Share by Application (2021-2032)
- 5.3 Global Atracurium Revenue by Application
- 5.3.1 Global Atracurium Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Atracurium Revenue by Application (2021-2032)
- 5.3.3 Global Atracurium Revenue Market Share by Application (2021-2032)
6 Global Atracurium Sales by Region
- 6.1 Global Atracurium Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Atracurium Sales by Region (2021-2032)
- 6.2.1 Global Atracurium Sales by Region (2021-2026)
- 6.2.2 Global Atracurium Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Atracurium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Atracurium Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Atracurium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Atracurium Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Atracurium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Atracurium Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Atracurium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Atracurium Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Atracurium Revenue by Region
- 7.1 Global Atracurium Revenue by Region
- 7.1.1 Global Atracurium Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Atracurium Revenue by Region (2021-2026)
- 7.1.3 Global Atracurium Revenue by Region (2027-2032)
- 7.1.4 Global Atracurium Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Atracurium Revenue (2021-2032)
- 7.2.2 North America Atracurium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Atracurium Revenue (2021-2032)
- 7.3.2 Europe Atracurium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Atracurium Revenue (2021-2032)
- 7.4.2 Asia-Pacific Atracurium Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Atracurium Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Atracurium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 HOSPIRA
- 8.1.1 HOSPIRA Company Information
- 8.1.2 HOSPIRA Business Overview
- 8.1.3 HOSPIRA Atracurium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 HOSPIRA Atracurium Product Portfolio
- 8.1.5 HOSPIRA Recent Developments
- 8.2 Joshi & Company
- 8.2.1 Joshi & Company Company Information
- 8.2.2 Joshi & Company Business Overview
- 8.2.3 Joshi & Company Atracurium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Joshi & Company Atracurium Product Portfolio
- 8.2.5 Joshi & Company Recent Developments
- 8.3 ZHEJIANG HAISEN PHARMACEUICAL
- 8.3.1 ZHEJIANG HAISEN PHARMACEUICAL Company Information
- 8.3.2 ZHEJIANG HAISEN PHARMACEUICAL Business Overview
- 8.3.3 ZHEJIANG HAISEN PHARMACEUICAL Atracurium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 ZHEJIANG HAISEN PHARMACEUICAL Atracurium Product Portfolio
- 8.3.5 ZHEJIANG HAISEN PHARMACEUICAL Recent Developments
- 8.4 GSK
- 8.4.1 GSK Company Information
- 8.4.2 GSK Business Overview
- 8.4.3 GSK Atracurium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GSK Atracurium Product Portfolio
- 8.4.5 GSK Recent Developments
- 8.5 Jiangsu Hengrui Medicine
- 8.5.1 Jiangsu Hengrui Medicine Company Information
- 8.5.2 Jiangsu Hengrui Medicine Business Overview
- 8.5.3 Jiangsu Hengrui Medicine Atracurium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Jiangsu Hengrui Medicine Atracurium Product Portfolio
- 8.5.5 Jiangsu Hengrui Medicine Recent Developments
- 8.6 Dongying (Jiangsu) Pharmaceutical
- 8.6.1 Dongying (Jiangsu) Pharmaceutical Company Information
- 8.6.2 Dongying (Jiangsu) Pharmaceutical Business Overview
- 8.6.3 Dongying (Jiangsu) Pharmaceutical Atracurium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Dongying (Jiangsu) Pharmaceutical Atracurium Product Portfolio
- 8.6.5 Dongying (Jiangsu) Pharmaceutical Recent Developments
- 8.7 Zhejiang Xianju Pharmaceutical
- 8.7.1 Zhejiang Xianju Pharmaceutical Company Information
- 8.7.2 Zhejiang Xianju Pharmaceutical Business Overview
- 8.7.3 Zhejiang Xianju Pharmaceutical Atracurium Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Zhejiang Xianju Pharmaceutical Atracurium Product Portfolio
- 8.7.5 Zhejiang Xianju Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Atracurium Value Chain Analysis
- 9.1.1 Atracurium Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Atracurium Production Mode & Process
- 9.2 Atracurium Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Atracurium Distributors
- 9.2.3 Atracurium Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst